Arginyl-glycyl-aspartic acid sequences and fibrinogen binding to platelets.

No abstract is available for this paper.

• Publication year

  1987

• Venue

  Blood

• Publication date

  1987-07-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1182/BLOOD.V70.1.110.BLOODJOURNAL701110PMID 3036276
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Platelet membrane glycoprotein IIb/IIIa: member of a family of Arg-Gly-Asp--specific adhesion receptors.

  1986cited by this paper
• Arg-Gly-Asp: a versatile cell recognition signal.

  1986cited by this paper
• Inhibition of platelet function with synthetic peptides designed to be high-affinity antagonists of fibrinogen binding to platelets.

  1986cited by this paper
• Evolution and structure of the fibrinogen genes. Random insertion of introns or selective loss?

  1985cited by this paper
• Fibronectin binding to thrombin-stimulated platelets: evidence for fibrin(ogen) independent and dependent pathways.

  1985cited by this paper
• Cloning and characterization of two cDNAs coding for human von Willebrand factor.

  1985cited by this paper
• Detachment of cells from culture substrate by soluble fibronectin peptides

  1985cited by this paper
• Inhibition of platelet adhesion to fibronectin, fibrinogen, and von Willebrand factor substrates by a synthetic tetrapeptide derived from the cell-binding domain of fibronectin.

  1985cited by this paper
• Inhibition of fibronectin binding to platelets by proteolytic fragments and synthetic peptides which support fibroblast adhesion.

  1985cited by this paper
• The effect of Arg-Gly-Asp-containing peptides on fibrinogen and von Willebrand factor binding to platelets.

  1985cited by this paper
• The tetrapeptide analogue of the cell attachment site of fibronectin inhibits platelet aggregation and fibrinogen binding to activated platelets.

  1985cited by this paper
• Interaction of fibronectin with its receptor on platelets.

  1985cited by this paper
• Evidence that three adhesive proteins interact with a common recognition site on activated platelets.

  1984cited by this paper
• Conformation of the carboxy-terminal region of the A alpha chain of fibrinogen as elucidated by immunochemical analyses.

  1984cited by this paper
• Cell attachment activity of fibronectin can be duplicated by small synthetic fragments of the molecule

  1984cited by this paper
• Biologically active synthetic fragments of epidermal growth factor: localization of a major receptor-binding region.

  1984cited by this paper
• The platelet-fibrinogen interaction. Evidence for proximity of the A alpha chain of fibrinogen to platelet membrane glycoproteins IIb/III.

  1984cited by this paper
• Platelet receptor recognition site on human fibrinogen. Synthesis and structure-function relationship of peptides corresponding to the carboxy-terminal segment of the gamma chain.

  1984cited by this paper
• The receptor-binding domain of human apolipoprotein E. Binding of apolipoprotein E fragments.

  1983cited by this paper
• Binding of fibrinogen to ADP-treated platelets. Comparison of plasma fibrinogen fractions and early plasmic fibrinogen derivatives.

  1983cited by this paper
• The receptor-binding domain of human apolipoprotein E. Monoclonal antibody inhibition of binding.

  1983cited by this paper
• Enhancement of the streptokinase-catalyzed activation of human plasminogen by human fibrinogen and its plasminolysis products.

  1982cited by this paper
• gamma and alpha chains of human fibrinogen possess sites reactive with human platelet receptors.

  1982cited by this paper
• The binding of fibrinogen to its platelet receptor.

  1982cited by this paper
• Exposure of fibrinogen receptor on human platelets by proteolytic enzymes.

  1981cited by this paper
• Specific and saturable binding of plasma fibronectin to thrombin-stimulated human platelets.

  1981cited by this paper
• Prediction of protein antigenic determinants from amino acid sequences.

  1981cited by this paper
• Effect of fibrinogen on ADP-induced platelet aggregation.

  1980cited by this paper
• Interaction of fibrinogen with its platelet receptor as part of a multistep reaction in ADP-induced platelet aggregation.

  1980cited by this paper
• Multimeric structure of factor VIII/von Willebrand factor in von Willebrand's disease.

  1980cited by this paper
• The amino acid sequence of the alpha-chain of human fibrinogen.

  1979cited by this paper
• Binding of soluble form of fibroblast surface protein, fibronectin, to collagen

  1977cited by this paper
• Significance of the intact polypeptide chains of human fibrinogen in ADP-induced platelet aggregation.

  1977cited by this paper
• Structure and function of fibrinogen.

  1977cited by this paper
• Amino acid sequence studies on plasmin-derived fragments of human fibrinogen: amino-terminal sequences of intermediate and terminal fragments.

  1975cited by this paper
• Amino acid sequence studies on the alpha chain of human fibrinogen. Location of four plasmin attack points and a covalent cross-linking site.

  1975cited by this paper
• Structure of plasmic degradation products of human fibrinogen. Fibrinopeptide and polypeptide chain analysis.

  1974cited by this paper
• The reliability of molecular weight determinations by dodecyl sulfate-polyacrylamide gel electrophoresis.

  1969cited by this paper
• Amino acid sequence studies on artiodactyl fibrinopeptides. I. Dromedary camel, mule deer, and cape buffalo.

  1967cited by this paper

• Variations in “Functional Site” Residues and Classification of Three-Finger Neurotoxins in Snake Venoms

  2025cites this paper
• Myokines and interorgan crosstalk: bridging exercise to health promotion and disease prevention

  2025cites this paper
• A nitric oxide-catalytically generating carboxymethyl chitosan/sodium alginate hydrogel coating mimicking endothelium function for improving the biocompatibility.

  2023cites this paper
• Functional properties of individual sub-domains of the fibrin(ogen) αC-domains.

  2023cites this paper
• From Secondary Intent to Accelerated Regenerative Healing: Emergence of the Bio-intelligent Scaffold Vasculogenic Strategy for Skin Reconstruction

  2021cites this paper
• Control of Blood Coagulation by Hemocompatible Material Surfaces—A Review

  2021cites this paper
• Fibrinogenolytic activity of protease from the culture fluid of Pleurotus ostreatus

  2020cites this paper
• Fibrinogen-binding proteins from Staphylococcus aureus

  2020cites this paper
• Emerging Therapies for Prehospital Control of Hemorrhage.

  2019cites this paper
• Transmission blockage of an orthotospovirus using synthetic peptides.

  2019cites this paper
• Irisin Mediates Effects on Bone and Fat via αV Integrin Receptors.

  2018cites this paper
• Epidemiological Studies of Soybean Vein Necrosis Virus and Potential Resistance Mechanisms to its Vector Neohydatothrips variabilis (Beach)

  2018cites this paper
• Joint inflammation related citrullination of functional arginines in extracellular proteins

  2017cites this paper
• The Future of Nanoparticle-Directed Venous Therapy

  2017cites this paper
• Peptide-Mediated Platelet Capture at Gold Micropore Arrays.

  2016cites this paper
• A multilevel study of platelet activation at biomaterial surface: from evaluatinhg to controlling hemocompatibility

  2016cites this paper
• Blood compatible materials: state of the art.

  2014cites this paper
• Interaction of platelets with poly(vinylidene fluoride-co-hexafluoropropylene) electrospun surfaces.

  2014cites this paper
• Arg-Gly-Asp recognition specificity Fibrinogen-endothelial cell interaction in vitro: a pathway mediated by an

  2013cites this paper
• A Novel Role for Pro-Coagulant Microvesicles in the Early Host Defense against Streptococcus pyogenes

  2013cites this paper
• Nanoparticles and the blood coagulation system. Part I: benefits of nanotechnology.

  2013cites this paper
• Microfluidics and coagulation biology.

  2013cites this paper
• A new Ser472Asn (Cab2a+) polymorphism localized within the αIIb “thigh” domain is involved in neonatal thrombocytopenia

  2011cites this paper
• in the presence of fibrinogen molecules containing gamma' chains The role of fibrinogen A alpha chains in ADP-induced platelet aggregation

  2011cites this paper
• Advantages of RGD peptides for directing cell association with biomaterials.

  2011cites this paper
• gamma B fibrinogen from rat plasma Purification and functional characterization of homodimeric gamma B

  2011cites this paper
• Historical perspective and future directions in platelet research

  2011cites this paper
• Photochemically crosslinked matrices of gelatin and fibrinogen promote rapid cell proliferation

  2011cites this paper
• Platelets release novel thiol isomerase enzymes which are recruited to the cell surface following activation

  2010cites this paper
• Magnetic Resonance Molecular Imaging of Thrombosis in an Arachidonic Acid Mouse Model Using an Activated Platelet Targeted Probe

  2010cites this paper
• Species differences in small molecule binding to (cid:1) IIb (cid:2) 3 are the result of sequence differences in 2 loops of the (cid:1) IIb (cid:2) propeller

  2009cites this paper
• In vitro and in vivo platelet targeting by cyclic RGD-modified liposomes.

  2009cites this paper
• The aqueous conformation of cyclo(1,6)Ac-Cys-Arg-Gly-Asp-Phe-Pen-NH2.

  2009cites this paper
• Design and evaluation of small peptides mapping the exposed surface of IL-8.

  2009cites this paper
• Species differences in small molecule binding to alpha IIb beta 3 are the result of sequence differences in 2 loops of the alpha IIb beta propeller.

  2009cites this paper
• Structural studies of two antiaggregant RGDW peptides by 1H and 13C NMR.

  2009cites this paper
• Aminopeptidase resistant Arg-Gly-Asp analogs are stable in plasma and inhibit platelet aggregation.

  2009cites this paper
• [Development of pegylated adenovirus vector for cancer gene therapy].

  2008cites this paper
• Allosteric regulation of αIIbβ3 by β3 95–105

  2008cites this paper
• Spécificité antigénique de l'Als3p de Candida albicans et implication de cette protéine dans l'interaction avec les constituants de l'hôte

  2007cites this paper
• Cell adhesion proteins and α-fetoprotein. Similar structural motifs as prerequisites for common functions

  2007cites this paper
• Interactions of ADP-stimulated human platelets with PEGylated polystyrene substrates prepared by surface amidation.

  2007cites this paper
• Bacitracin reveals a role for multiple thiol isomerases in platelet function

  2006cites this paper
• Integrins as targets in therapy

  2006cites this paper
• Engineering RGD-modified liposomes for targeted drug delivery to activated platelets.

  2006cites this paper
• Synthesis of modified fragments of fibrinogen and their effect on the activity of proteolytic enzymes

  2006cites this paper
• Fibronectin and cell adhesion: specificity of integrin-ligand interaction.

  2006cites this paper
• Fibrinogen-Endothelial Cell Interaction in Vitro : A Pathway Mediated by an Arg-Gly-Asp Recognition Specificity

  2005cites this paper
• The Role of Fibrinogen Aa Chains in ADP-tnduced Platelet Aggregation in the Presence of Fibrinogen Molecules Containing “ y ’ Chains

  2005cites this paper
• Integrin signaling in malignant melanoma

  2005cites this paper
• RGD-modified liposomes targeted to activated platelets as a potential vascular drug delivery system

  2004cites this paper
• Extracellular matrix-like surfactant polymers containing arginine-glycine-aspartic acid (RGD) peptides.

  2004cites this paper
• The role of cellular constituents and their interactions with the extracellular matrix through integrins in peritoneal healing and adhesion formation

  2003cites this paper
• RGD modified polymers: biomaterials for stimulated cell adhesion and beyond.

  2003cites this paper
• Variations in the ability of adsorbed fibrinogen to mediate platelet adhesion to polystyrene-based materials: a multivariate statistical analysis of antibody binding to the platelet binding sites of fibrinogen.

  2003cites this paper
• Eptifibatide: a potent inhibitor of the platelet receptor integrin glycoprotein IIb/IIIa

  2002cites this paper
• Activation of recombinant αIIbβ3 expressed in Chinese hamster ovary cells exposes different binding sites for fibrinogen or von Willebrand factor: evidence using monoclonal antibodies to αIIbβ3

  2002cites this paper
• A new platelet polymorphism Duv(a+), localized within the RGD binding domain of glycoprotein IIIa, is associated with neonatal thrombocytopenia.

  2002cites this paper
• Activation of recombinant alphaIIbbeta3 expressed in Chinese hamster ovary cells exposes different binding sites for fibrinogen or von Willebrand factor: evidence using monoclonal antibodies to alphaIIbbeta3.

  2002cites this paper
• Integrin-Dependent Interaction of Human Vascular Endothelial Cells on Biomimetic Peptide Surfactant Polymers

  2002cites this paper
• Pharmacological control of platelet function.

  2001cites this paper
• New Insights on Disintegrin-Receptor Interactions: Eristostatin and Melanoma Cells

  2001cites this paper
• Determination of the binding specificity of an integral membrane protein by saturation transfer difference NMR: RGD peptide ligands binding to integrin alphaIIbbeta3.

  2001cites this paper
• Orally active GPIIb/IIIa antagonists: synthesis and biological activities of masked amidines as prodrugs of 2-[(3S)-4.

  2001cites this paper
• The Effect of a Novel Glycoprotein IIb/IIIa Antagonist, SR 121566A, on Platelet Aggregation and Activation in Rhesus Monkeys

  2001cites this paper
• Evaluation of the role of proline residues flanking the RGD motif of dendroaspin, an inhibitior of platelet aggregation and cell adhesion.

  2001cites this paper
• The Role of Integrins in Peritoneal Healing

  2000cites this paper
• Antagonistas do receptor plaquetário GPIIb/IIIa

  2000cites this paper
• Differential antiplatelet efficacy for various GPIIb/IIIa antagonists: role of plasma calcium levels.

  2000cites this paper
• The synthesis and properties of Gla- and Phe-containing analogues of cyclic RGD pentapeptides

  2000cites this paper
• Peptide ligands can bind to distinct sites in integrin alphaIIbbeta3 and elicit different functional responses.

  1999cites this paper
• A new model of dual interacting ligand binding sites on integrin alphaIIbbeta3.

  1999cites this paper
• Fibrinogen receptor antagonists: design and clinical applications.

  1999cites this paper
• A New Model of Dual Interacting Ligand Binding Sites on Integrin αIIbβ3 *

  1999cites this paper
• Prodrug Approach for αΙΙbβ3-Peptidomimetic Antagonists to Enhance Their Transport in Monolayers of a Human Intestinal Cell Line (Caco-2): Comparison of In Vitro and In Vivo Data

  1999cites this paper
• Peptide Ligands Can Bind to Distinct Sites in Integrin αIIbβ3 and Elicit Different Functional Responses*

  1999cites this paper
• Residence-time dependent changes in fibrinogen adsorbed to polymeric biomaterials.

  1999cites this paper
• Prodrug approach for alphaIIbbeta3-peptidomimetic antagonists to enhance their transport in monolayers of a human intestinal cell line (Caco-2): comparison of in vitro and in vivo data.

  1999cites this paper
• Chapter II.6 – Cell-Synthetic Surface Interactions

  1998cites this paper
• The covalent coupling of Arg-Gly-Asp-containing peptides to liposomes: purification and biochemical function of the lipopeptide.

  1998cites this paper
• In contrast to fibrinogen or fibrin, peptide and peptide mimetic binding to alphaIIbbeta3 (GPIIb-IIIa) does not cause outside-in signalling as judged by measurements of phosphatidylinositol 4,5-bisphosphate.

  1998cites this paper
• Novel non-peptide fibrinogen receptor antagonists. 1. Synthesis and glycoprotein IIb-IIIa antagonistic activities of 1,3,4-trisubstituted 2-oxopiperazine derivatives incorporating side-chain functions of the RGDF peptide.

  1998cites this paper
• Inhibition of platelet-mediated clot retraction by integrin antagonists.

  1998cites this paper
• In contrast to fibrinogen or fibrin, peptide and peptide mimetic binding to alpha does not cause outside-in signalling as judged by measurements of phosphatidylinositol 4,5-bisphosphate beta (GPIIb-IIIa) IIb 3

  1998cites this paper
• New orally active non-peptide fibrinogen receptor (GpIIb-IIIa) antagonists: identification of ethyl 3-[N-[4-[4-[amino[(ethoxycarbonyl) imino]methyl]phenyl]-1,3-thiazol-2-yl]-N-[1-[(ethoxycarbonyl)methyl]pip erid -4-yl]amino]propionate (SR 121787) as a potent and long-acting antithrombotic agent.

  1997cites this paper
• The interaction of disagregin with the platelet fibrinogen receptor, glycoprotein IIb-IIIa.

  1997cites this paper
• Integrin alpha IIb beta 3 and platelet function.

  1997cites this paper
• Integrin αIIbβ3 and Platelet Function

  1997cites this paper
• Interaction of Thrombin‐activated Platelets with Extracellular Matrices (Fibronectin and Vitronectin): Comparison of the Activity of Arg‐Gly‐Asp‐containing Venom Peptides and Monoclonal Antibodies Against Glycoprotein IIb/IIIa Complex

  1997cites this paper
• RGD-DEPENDENT INTEGRINS

  1997cites this paper
• Recognition Sites of RGD-Dependent Integrins

  1997cites this paper
• Triflavin inhibits platelet-induced vasoconstriction in de-endothelialized aorta.

  1997cites this paper
• A very short, efficient and inexpensive synthesis of the prodrug form of SC-54701A a platelet aggregation inhibitor

  1997cites this paper
• Antagonism of the GPIIb/IIIa receptor with the nonpeptidic molecule BIBU52: inhibition of platelet aggregation in vitro and antithrombotic efficacy in vivo.

  1997cites this paper
• The integrin family

  1996cites this paper
• Substitutions of Proline 42 to Alanine and Methionine 46 to Asparagine around the RGD Domain of the Neurotoxin Dendroaspin Alter Its Preferential Antagonism to That Resembling the Disintegrin Elegantin (*)

  1996cites this paper
• Plasma fibrinogen inhibits platelets adhesion in flowing blood to immobilized fibrinogen.

  1996cites this paper
• Impaired platelet aggregation and sustained bleeding in mice lacking the fibrinogen motif bound by integrin alpha IIb beta 3.

  1996cites this paper
• Ligand binding and affinity modulation of integrins.

  1996cites this paper
• Platelet aggregation is inhibited by phycolectins

  1996cites this paper